Aurinia Pharmaceuticals (AUPH) 10-Q2024 Q2 Quarterly report

Filed: 1 Aug 24, 6:07am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: antidilutive, Ascending, BAFF, distributor, Factor, forward, insignificant, issuable, Ligand, moving, overhead, SAD, tolerability, treasury

Removed: acid, activation, administered, amino, binding, Bioscience, calcineurin, canceled, CNI, Columbia, combination, computation, coupled, cyclosporine, cytokine, demonstrate, differentiation, earlier, exercised, expression, fixed, immune, immunosuppressant, improve, ingredient, inhibiting, interleukin, licensing, macrophage, make, mechanism, mediated, MMF, modification, modulation, molecule, month, obsolete, orally, organ, pharmacologic, prevention, private, protect, proteinuria, rejection, resulting, rheumatoid, Riptide, secured, sicca, solid, terminated, undergoing, validated, Victoria

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated AUPH transcripts

AUPH similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Aurinia Pharmaceuticals Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph Miller, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


Date:	July 31, 2024	By:	/s/ Joseph Miller
			Joseph Miller
			Chief Financial Officer
			(Principal Financial and Accounting Officer)